Form 10-Q CODEXIS, INC. For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Crypto stocks rise premarket as Bitcoin hits over seven-month high
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- FortuneX and WT Realty announce $600M merger deal
Stifel on Codexis, Inc. (CDXS): 'Key Milestones On the Horizon in 2H25'
August 14, 2025 10:35 AM EDTStifel analyst Daniel Arias reiterated a Buy rating and $5.00 price target on Codexis, Inc. (NASDAQ: CDXS).
The analyst comments "CDXS beat consensus on revs and provided a briefing on the encouraging status of the Pharma Biocatalysis business and the ECO Synthesis... More
